GlassScriptPhysician profile
John R Kao
NPI 1497737191
$19,959.72
in general payments reported to CMS, 2019-2025
53 companies · $3,451 in 2025
The $3,451 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,358 · 2020: $2,493 · 2021: $1,896 · 2022: $2,408 · 2023: $2,664 · 2024: $2,690 · 2025: $3,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,792 · Consulting Fee: $12.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,792.08 |
| Consulting Fee | $12.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,057.06 | 2019-2025 | Edora 8 Dr-T, Amvia Edge, Biomonitor |
| Novartis Pharmaceuticals Corporation | $1,909.72 | 2019-2025 | |
| Amgen INC. | $1,482.84 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $1,423.24 | 2019-2023 | Diamondback Coronary |
| Philips North America LLC | $1,374.89 | 2019-2025 | Coronary Other, Coronary Undivided, (P88) Igt Devices Fm |
| E.R. Squibb & Sons, L.L.C. | $1,079.87 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $911.43 | 2019-2025 | Optis, Cardiomems, Diamondback Coronary |
| Boston Scientific Corporation | $798.17 | 2019-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $779.01 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $602.16 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $593.89 | 2019-2024 | Farxiga, Lokelma, Brilinta |
| Pfizer INC. | $561.44 | 2019-2025 | |
| Abiomed | $525.22 | 2019-2025 | |
| Shockwave Medical, INC | $498.91 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $452.10 | 2019-2024 | Opsumit, Uptravi |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $443.85 | 2019-2021 | |
| Esperion Therapeutics, INC. | $426.97 | 2020-2025 | Nexletol |
| Bardy Diagnostics, INC. | $311.09 | 2019-2022 | |
| Novo Nordisk INC | $242.57 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $230.50 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $224.06 | 2022 | |
| Inari Medical, INC. | $223.94 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $215.27 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $203.05 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $197.41 | 2021-2023 | Arcalyst |
| Medtronic Vascular, INC. | $190.45 | 2020 | |
| Medtronic, INC. | $176.66 | 2021-2023 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.29 | 2023-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $141.22 | 2019-2024 | Evkeeza |
| Medtronic USA, INC. | $132.30 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $126.35 | 2019-2021 | |
| Biosense Webster, INC. | $124.99 | 2019 | |
| Alnylam Pharmaceuticals INC. | $121.55 | 2021-2025 | Amvuttra |
| Penumbra, INC. | $113.15 | 2023 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.44 | 2023-2025 | Lifevest |
| Heartflow, INC. | $105.03 | 2021-2025 | |
| Asahi Intecc USA, INC. | $87.77 | 2019 | |
| Gilead Sciences, INC. | $66.82 | 2019 | |
| Baxter Healthcare | $64.61 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $60.86 | 2024-2025 | |
| Atricure, INC. | $60.28 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Astellas Pharma US INC | $59.10 | 2019-2022 | |
| Akcea Therapeutics, INC. | $54.83 | 2019 | |
| Lundbeck LLC | $45.85 | 2019-2020 | |
| Terumo Medical Corporation | $40.18 | 2023 | Heartrail |
| Agepha Pharma Fz LLC | $29.79 | 2025 | Lodoco |
| Cardiva Medical, INC. | $22.11 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $20.35 | 2022 | |
| Glaxosmithkline, LLC. | $19.57 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $18.73 | 2025 | |
| Kestra Medical Technology Services, INC. | $17.47 | 2024 | Assure Wcd |
| Aegerion Pharmaceuticals, INC. | $17.33 | 2019 | |
| Chiesi USA, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.